European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

M Lawler, L Davies, S Oberst, K Oliver… - The Lancet …, 2023 - thelancet.com
Cancer research is a crucial pillar for countries to deliver more affordable, higher quality,
and more equitable cancer care. Patients treated in research-active hospitals have better …

[HTML][HTML] Cancer survivors' experience with telehealth: a systematic review and thematic synthesis

A Cox, G Lucas, A Marcu, M Piano, W Grosvenor… - Journal of medical …, 2017 - jmir.org
Background Net survival rates of cancer are increasing worldwide, placing a strain on health
service provision. There is a drive to transfer the care of cancer survivors—individuals living …

[HTML][HTML] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

G Curigliano, D Lenihan, M Fradley, S Ganatra… - Annals of …, 2020 - Elsevier
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries

H Zeng, W Chen, R Zheng, S Zhang, JS Ji… - The Lancet Global …, 2018 - thelancet.com
Summary Background From 2003 to 2005, standardised 5-year cancer survival in China
was much lower than in developed countries and varied substantially by geographical area …

Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the American and European cardio‐oncology guidelines

J Alexandre, J Cautela, S Ederhy… - Journal of the …, 2020 - Am Heart Assoc
The considerable progress made in the field of cancer treatment has led to a dramatic
improvement in the prognosis of patients with cancer. However, toxicities resulting from …

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from …

C Allemani, T Matsuda, V Di Carlo, R Harewood… - The Lancet, 2018 - thelancet.com
Background In 2015, the second cycle of the CONCORD programme established global
surveillance of cancer survival as a metric of the effectiveness of health systems and to …

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to …

C Fitzmaurice, C Allen, RM Barber, L Barregard… - JAMA …, 2017 - jamanetwork.com
Importance Cancer is the second leading cause of death worldwide. Current estimates on
the burden of cancer are needed for cancer control planning. Objective To estimate …

[HTML][HTML] Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups …

Global Burden of Disease Cancer Collaboration - JAMA oncology, 2017 - ncbi.nlm.nih.gov
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With
Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 - PMC Back …

[HTML][HTML] Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries …

C Allemani, HK Weir, H Carreira, R Harewood, D Spika… - The lancet, 2015 - thelancet.com
Background Worldwide data for cancer survival are scarce. We aimed to initiate worldwide
surveillance of cancer survival by central analysis of population-based registry data, as a …

[HTML][HTML] 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a …

M Quaresma, MP Coleman, B Rachet - The lancet, 2015 - thelancet.com
Background Assessment of progress in cancer control at the population level is increasingly
important. Population-based survival trends provide a key insight into the overall …